table of content
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Nuclear Medicine Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Nuclear Medicine Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Nuclear Medicine Diagnostics Overall Market Size
2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size: 2022 VS 2029
2.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Nuclear Medicine Diagnostics Players in Global Market
3.2 Top Global Prostate Cancer Nuclear Medicine Diagnostics Companies Ranked by Revenue
3.3 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Nuclear Medicine Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Nuclear Medicine Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Nuclear Medicine Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Nuclear Medicine Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Nuclear Medicine Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Markets, 2022 & 2029
4.1.2 SPECT
4.1.3 PET
4.2 By Type - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2018-2029
6.3.2 US Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.3.3 Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.3.4 Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2018-2029
6.4.2 Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.4.3 France Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.4.4 U.K. Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.4.5 Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.4.6 Russia Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.4.8 Benelux Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2018-2029
6.5.2 China Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.5.3 Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.5.4 South Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.5.6 India Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2018-2029
6.6.2 Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.6.3 Argentina Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2018-2029
6.7.2 Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.7.3 Israel Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
6.7.5 UAE Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2018-2029
7 Prostate Cancer Nuclear Medicine Diagnostics Companies Profiles
7.1 Blue Earth Diagnostics
7.1.1 Blue Earth Diagnostics Company Summary
7.1.2 Blue Earth Diagnostics Business Overview
7.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.1.4 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Blue Earth Diagnostics Key News & Latest Developments
7.2 PETNET Solutions
7.2.1 PETNET Solutions Company Summary
7.2.2 PETNET Solutions Business Overview
7.2.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.2.4 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2018-2023)
7.2.5 PETNET Solutions Key News & Latest Developments
7.3 Cardinal Health
7.3.1 Cardinal Health Company Summary
7.3.2 Cardinal Health Business Overview
7.3.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.3.4 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Cardinal Health Key News & Latest Developments
7.4 Lantheus Medical Imaging
7.4.1 Lantheus Medical Imaging Company Summary
7.4.2 Lantheus Medical Imaging Business Overview
7.4.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.4.4 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Lantheus Medical Imaging Key News & Latest Developments
7.5 Jubilant Pharma
7.5.1 Jubilant Pharma Company Summary
7.5.2 Jubilant Pharma Business Overview
7.5.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.5.4 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Jubilant Pharma Key News & Latest Developments
7.6 NCM-USA
7.6.1 NCM-USA Company Summary
7.6.2 NCM-USA Business Overview
7.6.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.6.4 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2018-2023)
7.6.5 NCM-USA Key News & Latest Developments
7.7 Progenics Pharma
7.7.1 Progenics Pharma Company Summary
7.7.2 Progenics Pharma Business Overview
7.7.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.7.4 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Progenics Pharma Key News & Latest Developments
7.8 Telix Pharma
7.8.1 Telix Pharma Company Summary
7.8.2 Telix Pharma Business Overview
7.8.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.8.4 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Telix Pharma Key News & Latest Developments
7.9 ImaginAb
7.9.1 ImaginAb Company Summary
7.9.2 ImaginAb Business Overview
7.9.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.9.4 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2018-2023)
7.9.5 ImaginAb Key News & Latest Developments
7.10 Theragnostics
7.10.1 Theragnostics Company Summary
7.10.2 Theragnostics Business Overview
7.10.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.10.4 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Theragnostics Key News & Latest Developments
7.11 Novartis
7.11.1 Novartis Company Summary
7.11.2 Novartis Business Overview
7.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.11.4 Novartis Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Novartis Key News & Latest Developments
7.12 Alliance Medical
7.12.1 Alliance Medical Company Summary
7.12.2 Alliance Medical Business Overview
7.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
7.12.4 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2018-2023)
7.12.5 Alliance Medical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
